• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 7/9/24: How Real-World Data and AI Are Transforming Clinical Trials, Protecting Your Data with Hamster Names and Greek Wars & more


The latest news for pharma industry insiders.

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.

Data-Driven Development: How Real-World Data and AI Are Transforming Clinical Trials

Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.

A Patient-First Approach to Clinical Research: A Conversation With Industry Leaders

Are you ready to level up your approach to clinical trials by shifting your mindset to view patients and caregivers as key stakeholders? Harnessing the patient’s voice has become indispensable to trial design, with patient and caregiver feedback critical to trial success. Join a group of industry leaders for a conversation on how to design and execute patient-centric clinical trials.

To Protect Your Data, Try Hamster Names and Greek Wars

Two-step verification no longer seems like enough security. Why not four or five?

Biostate AI Launches Total RNA Sequencing and Free Data Analysis AI

Biostate AI, the scalable biodata foundry startup, emerges from stealth today with the launch of two service products: Total RNA sequencing and Copilot for RNAseq data analysis. Biostate AI aims to partner and collaborate with academic researchers, hospital biorepositories, and pharma/biotech companies, leveraging its new technologies for scalable multiomic data collection, scientific discovery, and AI training.

MMIT (Managed Markets Insight & Technology) on LinkedIn

Personalized patient messages, influencer content creation, AI trends, combatting misinformation: these are just some of what's discussed in Pharmaceutical Executive's recent roundtable.

Featured are MMIT’s Jay Shah, Senior Solutions Engineer, and Glen Saunders, VP of Product Management and Strategy, at Skipta.

📹 Watch the full conversation: https://ow.ly/CzJx50Rw8cn.

#PharmaMarketing #DigitalHealthTrends #PatientEngagement #Influencer

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs